Menu
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full spectrum of patient needs. Accuray is dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as they partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide.
1310 Chesapeake Ter
Sunnyvale, California 94089
Phone: 14087164600
www.accuray.com
Accuray''s new CE-marked Helix™ radiotherapy system brings advanced cancer care to emerging markets. High-performance, cost-effective treatment for various cancers, designed to boost clinic productivity and personalize patient care.
Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company''s strategic plan to expand its portfolio of helical radiation therapy delivery systems MADISON,…
Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company''s strategic plan to expand its portfolio of helical radiation therapy delivery systems MADISON, Wis. , Aug.
Accuray Inc (ARAY) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue Growth Amid Market Challenges
Q4 2024 Accuray Inc Earnings Call Transcript
Accuray Incorporated (NASDAQ: ARAY ) and Halifax Health announced a breakthrough in cancer treatment at the Charles L. and Miki N. Grant Cancer Center for Hope in Port Orange, FL. The center''s medical team became the first in the United States to treat cancer patients using Accuray''s Radixact System with VitalHold technology. This innovative system is designed to enhance the precision of radiation therapy by improving patient positioning and monitoring throughout the treatment process, offering a new standard of care for a wide range of cancer cases, including breast cancer. Significance of Radixact Per Accuray, Radixact System, backed by VitalHold and other advanced technologies like ClearRT helical CT imaging and Synchrony real-time adaptive delivery, represents a significant advancement in radiotherapy. VitalHold''s surface-guided radiotherapy (SGRT) ensures accurate patient positioning, improving the reproducibility of treatments and enabling deep inspiration breath hold techniques.
https://www.investing.com/news/stock-market-news/earnings-call-accuray-reports-robust-growth-amid-market-challenges-93CH-3573251
Accuray Incorporated (NASDAQ:NASDAQ:ARAY) Q4 2024 Earnings Call Transcript August 14, 2024 4:30 PM ETCompany ParticipantsJesse Chew - SVP and Chief Legal…
Accuray (NASDAQ: ARAY ) just reported results for the fourth quarter of 2024. Accuray reported earnings per share of 3 cents. This met the analyst estimate for EPS of 3 cents. The company reported revenue of $134.29 million. This was 10.52% better than the analyst estimate for revenue of $121.51 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post ARAY Stock Earnings: Accuray Meets EPS, Beats Revenue for Q4 2024 appeared first on InvestorPlace .
